Neurobit

United States
Troy, New Hampshire, United States, 10036

Company profile

Neurobit company profile

Neurobit is a leading medical technology company that develops Software as a Medical Device (SaMD) powered by AI to decipher intricate patterns in health vitals measured during sleep, termed 'sleep biomarkers'. This technology aids in delivering tailored, predictive, and precision healthcare. With a vision to establish a universally accessible health analytics system, Neurobit aims to enhance care quality and efficiency for healthcare professionals and patients. Our Biomarker Bridge initiative is at the forefront of this mission—creating a collaborative platform that connects AI-driven biomarker companies, enabling cross-disciplinary innovation, and accelerating the integration of digital biomarkers into clinical practice. Globally, over 150 esteemed universities, hospitals, and R&D centers rely on our advanced technology solutions to push the boundaries of healthcare innovation.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-06-28

Headquarters

Postal code
10036
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
7
Total equity funding
$1.4M
Last funding
Seed / $100,000 / 2023-04-01
Last equity funding
Seed / $100,000
Investors
3
Founders
2
Articles
14

Founders and investors

Founders

Amiya PatanaikKishan Kishan

Investors

Enterprise SingaporeEntrepreneurs FirstiHealthtech ,NUS